1. In the fiscal third quarter, the three months ending March 31, 2025, Ascension’s recurring operating loss was $68 million, reflecting a $1.4 billion improvement from the fourth quarter of fiscal ...

Precipio is a microcap specialty cancer diagnostics company offering both molecular assay kits and pathology services. Precipio currently has "going concern" language in their financial audit due to ...

2024 revenues rose 6.3% to €654.5 million Recurring operating income (1) increased 24.7% to €39.5 million Recurring operating margin came to 6.0% in 2024, up from 5.1% in 2023 Boulogne-Billancourt, ...

Management uses both GAAP and non-GAAP financial measures to analyze and assess the overall performance of the business, to make operating decisions and to forecast and plan for future periods. We ...